For the sixth year in a row, Xconomy will hold our fall Boston life sciences event, “Boston’s Life Science Disruptors”, on Wednesday October 17 at MIT’s Koch Institute in Kendall Square. Join us for this unique event featuring candid stories from some of New England’s most radical biotech company leaders, founders, and VC backers who are out to change the game in the life sciences.
You can get your tickets here.
— David Liu, Co-founder, Beam Therapeutics; Faculty Vice-Chair and Core Member, Broad Institute
— John Evans, CEO & Board Member, Beam Therapeutics
— Aviv Regev, Scientific Founder, Celsius Therapeutics; Faculty Chair and Core Member, Broad Institute
— Alexis Borisy, Chair, Celsius Therapeutics; Partner, Third Rock Ventures
— Christoph Lengauer, President, Celsius Therapeutics
— Jennifer Petter, Founder & Chief Scientific Officer, Arrakis Therapeutics
— Michael Gilman, CEO, Arrakis Therapeutics
Space is limited at this event, so make sure to register today to save $50. See you there on Oct. 17!